ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist I at Generate:Biomedicines - ApplyBlast

Scientist I

Generate:Biomedicines

3 days ago

4.0 on Glassdoor

Somerville, Massachusetts, United States

Onsite

Full Time

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Generate Biomedicines is seeking a Scientist I with expertise in cancer biology to support the discovery and development of protein-based oncology therapeutics. This highly laboratory-focused role involves planning and executing cellular assays, interpreting results, and generating reproducible data to inform project decisions within a multidisciplinary team.

Responsibilities

Establish and characterize cancer cell lines and tumor organoids
Generate and validate engineered cell lines using CRISPR and transfection
Design and execute cell viability and cytotoxicity assays

Skills

Qualifications

Ph.D. in cancer biology, cell biology, immunology, immuno-oncology, or a related fieldmaster’s degree in a related fieldbachelor’s degree in a related field

About Generate:Biomedicines

generatebiomedicines.com

Headquarters

Somerville, Massachusetts, United States

Company Size

201-500 employees

View Profile

Generate:Biomedicines is a therapeutics company that combines machine learning, computational biology, and biological engineering to design and develop precision protein medicines and antibodies. Using generative AI and lab-driven engineering, the company builds targeted biologics and epitope-focused candidates, advancing a pipeline from discovery through clinical development. Its clinical-stage programs include GB-0895, a long‑acting anti‑TSLP antibody progressing to global Phase 3 studies, and the company has recently completed an initial public offering. Generate was incubated by Flagship Pioneering and emphasizes platform-driven discovery to accelerate novel biologic therapeutics.